Literature DB >> 3074625

Potent selective vasoconstrictor effects of endothelin in the pig kidney in vivo.

J Pernow1, J F Boutier, A Franco-Cereceda, J S Lacroix, R Matran, J M Lundberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3074625     DOI: 10.1111/j.1748-1716.1998.tb08538.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


× No keyword cloud information.
  8 in total

1.  High sensitivity of porcine cerebral arteries to endothelin.

Authors:  S Fukuda; K Taga; K Shimoji
Journal:  Experientia       Date:  1991-05-15

2.  Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis.

Authors:  J F Pittet; D R Morel; A Hemsen; K Gunning; J S Lacroix; P M Suter; J M Lundberg
Journal:  Ann Surg       Date:  1991-03       Impact factor: 12.969

3.  Nitric oxide modulates renal vasoconstrictor effect of endothelin-1 in conscious lambs.

Authors:  Francine G Smith; Liesbeth van der Velde; Alp Sener
Journal:  Pediatr Nephrol       Date:  2005-08-16       Impact factor: 3.714

Review 4.  Endothelin: potential role in development and disease.

Authors:  V Kon; A Fogo
Journal:  Pediatr Nephrol       Date:  1993-12       Impact factor: 3.714

5.  The effect of bosentan on the pharmacokinetics of digoxin in healthy male subjects.

Authors:  C Weber; L Banken; H Birnboeck; S Nave; R Schulz
Journal:  Br J Clin Pharmacol       Date:  1999-06       Impact factor: 4.335

6.  Actions of constrictor (NPY and endothelin) and dilator (substance P, CGRP and VIP) peptides on pig splenic and human skeletal muscle arteries: involvement of the endothelium.

Authors:  J Pernow
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

7.  Endothelin- and neuropeptide Y-induced vasoconstriction of human epicardial coronary arteries in vitro.

Authors:  A Franco-Cereceda
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

8.  Characterization of endothelin receptors in rat renal artery in vitro.

Authors:  K L Clark; L Pierre
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.